Is chemotherapy a good option for my advanced prostate cancer? APC experts, Dr. Russell Szmulewitz, Dr. Emmanuel Antonarakis, Malecare Director, Joel Nowak, and moderator, Dr. Tomasz Beer, discuss the efficacy of chemotherapy for prostate cancer patients. The panel shares information on quality of life studies and TUPOR...
Read More
In a nutshell This study examined the long-term recovery rates from urinary incontinence (UI) and erectile dysfunction (ED) for men with prostate cancer treated with surgery. Researchers concluded that men with UI or ED 12 months after prostate surgery have a high chance of late recovery. Some background Prostate surgery is one of the treatment...
Read More
The northern hemisphere is experiencing all that autumn brings–colors in reds, golds, purples, browns and orange. Leaves, squash, corn, potatoes and pumpkins are the flowers of fall. Potatoes, first cultivated by the Incas, are now one of the largest food crops worldwide. To celebrate autumn we are sharing another recipe by Holly Clegg called...
Read More
In a nutshell This study reviewed evidence on the use of medication and supplements for additional medical conditions on prostate cancer mortality. Authors concluded that commonly used medications and supplements can influence prognosis among prostate cancer patients. Some background Prostate cancer is more common among older men. Older men...
Read More
In a nutshell This study compared the effectiveness of different treatment options available for localized prostate cancer. Authors reported low rates of prostate cancer-specific mortality across all treatment groups. However, surgery and radiation therapy were associated with a lower rate of disease progression and metastases compared to active...
Read More
In a nutshell This study examined the effectiveness of biopsies guided by imaging techniques in detecting prostate cancer upgrades during active surveillance. Researchers advised that clinicians may consider using both systematic (conventional) and imaging guided biopsies during active surveillance. Some background Some men with low- or...
Read More
In a nutshell The authors aimed to determine the risks of unfavorable disease and predictors of adverse outcomes in men with Gleason score 3 + 4 prostate cancer and how this would affect active surveillance. The authors concluded that active surveillance is a potential treatment option in men with Gleason score 3+4, low PSA scores and low-stage...
Read More
In a nutshell The authors aimed to determine the benefits and drawbacks of prostate cancer treatment in patients who suffer from pre-treatment urinary problems. The authors concluded that patients with pre-treatment urinary problems benefitted from prostate surgery. Some background Prostate surgery involves surgically removing the prostate...
Read More
In a nutshell This study examined the effects of enzalutamide (Xtandi) in men with metastatic castration-resistant prostate cancer (mCRPC) that has spread to the lungs and/or liver. Researchers reported that enzalutamide is safe and effective for men with mCRPC affecting the lung or liver. Some background When prostate cancer spreads outside of...
Read MoreIn a nutshell This study compared the side effects of external beam radiation therapy (EBRT) and hypofractioned EBRT (H-EBRT) on erectile and sexual function. Researchers reported similar effects of EBRT and H-EBRT on erectile and sexual function up to 3 years after treatment. Some background Radiation therapy is a common treatment for localized...
Read More
In a nutshell This study compared the safety and effectiveness of external beam radiation therapy (EBRT) and hypofractioned EBRT (H-EBRT) for localized prostate cancer. Researchers reported no differences in survival or disease recurrence rates between high H-EBRT and EBRT. Some background Radiation therapy is a common treatment for localized...
Read More
In a nutshell This study examined the benefit of adding chemotherapy to androgen deprivation therapy (ADT) early to treat metastatic hormone-sensitive prostate cancer. Researchers reported a survival benefit when chemotherapy was added to ADT. This benefit was only detected with chemotherapy involving docetaxel (Taxotere). Some background ADT is a...
Read More
